{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:46:45Z","timestamp":1788997605636,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:00:00Z","timestamp":1610841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jfma.2021.01.015","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T09:12:46Z","timestamp":1612516366000},"page":"1967-1976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma"],"prefix":"10.1016","volume":"120","author":[{"given":"Shin-Yu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-Sang","family":"Hsue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2021.01.015_bib1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jfma.2021.01.015_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canep.2018.06.003","article-title":"Epidemiology of multiple myeloma in Taiwan, a population based study","volume":"55","author":"Huang","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jfma.2021.01.015_bib3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3816\/CLML.2010.n.080","article-title":"Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma","volume":"10","author":"Talamo","year":"2010","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.jfma.2021.01.015_bib4","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jfma.2021.01.015_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.2014.117176","article-title":"European Myeloma Network. European Myeloma Network guidelines for the management of multiple myeloma related complications","volume":"100","author":"Terpos","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jfma.2021.01.015_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4314\/gmj.v53i1.8","article-title":"Presentation and survival of multiple myeloma patients in Ghana: a review of 169 cases","volume":"53","author":"Acquah","year":"2019","journal-title":"Ghana Med J"},{"key":"10.1016\/j.jfma.2021.01.015_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5312\/wjo.v5.i3.272","article-title":"Imaging of multiple myeloma: current concepts","volume":"5","author":"Derlin","year":"2014","journal-title":"World J Orthoped"},{"key":"10.1016\/j.jfma.2021.01.015_bib8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00277-009-0829-0","article-title":"Role of radiography, MRI and FDG-PET\/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma","volume":"88","author":"L\u00fctje","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jfma.2021.01.015_bib9","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1038\/bcj.2017.78","article-title":"Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group","volume":"7","author":"Hillengass","year":"2017","journal-title":"Blood Canc J"},{"key":"10.1016\/j.jfma.2021.01.015_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-014-0308-3","article-title":"F-FDG pet\/ct: a review of diagnostic and prognostic features in multiple myeloma and related disorders","volume":"15","author":"Dammacco","year":"2015","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jfma.2021.01.015_bib11","first-page":"38","article-title":"Panoramic and skull imaging may aid in the identification of multiple myeloma lesions","volume":"23","author":"Faria","year":"2018","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.jfma.2021.01.015_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0030-4220(88)90135-1","article-title":"Incidence of jaw lesions in 193 patients with multiple myeloma","volume":"65","author":"Lambertenghi-Deliliers","year":"1988","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.jfma.2021.01.015_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0030-4220(84)90182-8","article-title":"Maxillofacial manifestations of multiple myeloma. An unusual case and review of the literature","volume":"57","author":"Epstein","year":"1984","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.jfma.2021.01.015_bib14","first-page":"1071","article-title":"Imaging of jaw lesions related to multiple myeloma","volume":"5","author":"Feitosa Cavalcanti1","year":"2017","journal-title":"J Radiol Radiat Ther"},{"key":"10.1016\/j.jfma.2021.01.015_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0278-2391(97)90687-X","article-title":"Radiographic manifestations of multiple myeloma in the mandible: a retrospective study of 77 patients","volume":"55","author":"Witt","year":"1997","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jfma.2021.01.015_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hed.10210","article-title":"Myeloma of the jaw bones: a clinicopathologic study of 33 cases","volume":"25","author":"Lae","year":"2003","journal-title":"Head Neck"},{"key":"10.1016\/j.jfma.2021.01.015_bib17","first-page":"259","article-title":"The multiple oral presentations of multiple myeloma","volume":"22","author":"Cardoso","year":"2014","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jfma.2021.01.015_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bjhh.2017.08.006","article-title":"Can dentists detect multiple myeloma through oral manifestations?","volume":"40","author":"De Almeida","year":"2018","journal-title":"Hematol transfus cell ther"},{"key":"10.1016\/j.jfma.2021.01.015_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.oraloncology.2007.09.012","article-title":"Metastatic tumours to the oral cavity-pathogenesis and analysis of 673 cases","volume":"44","author":"Hirshberg","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jfma.2021.01.015_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.adaj.2017.12.028","article-title":"Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates","volume":"149","author":"Faria","year":"2018","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.jfma.2021.01.015_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/pharmaceutics10040202","article-title":"Myeloma bone disease: update on pathogenesis and novel treatment strategies","volume":"10","author":"Vallet","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jfma.2021.01.015_bib22","first-page":"33","article-title":"Bone disease in multiple myeloma: pathophysiology and management","volume":"7","author":"Hameed","year":"2014","journal-title":"Canc Growth Metastasis"},{"key":"10.1016\/j.jfma.2021.01.015_bib23","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2014-09-568915","article-title":"Frontline therapy of multiple myeloma","volume":"125","author":"Moreau","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2021.01.015_bib24","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jfma.2021.01.015_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-160X-6-11","article-title":"Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients","volume":"6","author":"Walter","year":"2010","journal-title":"Head Face Med"},{"key":"10.1016\/j.jfma.2021.01.015_bib26","first-page":"56","article-title":"Prognostic factors in multiple myeloma","volume":"2","author":"Kyle","year":"1995","journal-title":"Stem Cell"},{"key":"10.1016\/j.jfma.2021.01.015_bib27","first-page":"152","article-title":"A comparison of different staging systems for multiple myeloma: can the MRI pattern play a prognostic role?","volume":"209","author":"Filonzi","year":"2017","journal-title":"Am Journal Rev"},{"key":"10.1016\/j.jfma.2021.01.015_bib28","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"Blade J et\u00a0al. International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jfma.2021.01.015_bib29","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/leu.2009.61","article-title":"Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant","volume":"23","author":"Hari","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.jfma.2021.01.015_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.canep.2012.05.002","article-title":"Risk factors for multiple myeloma: a hospital-based case-control study in Northwest China","volume":"36","author":"Wang","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jfma.2021.01.015_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2141.2012.09124.x","article-title":"Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups","volume":"158","author":"Ailawadhi","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jfma.2021.01.015_bib32","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jfma.2021.01.015_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1259\/dmfr\/27458726","article-title":"Clinical and diagnostic imaging of bisphosphonate associated osteonecrosis of the jaws","volume":"35","author":"Chiandussi","year":"2006","journal-title":"Dentomaxillofacial Radiol"},{"key":"10.1016\/j.jfma.2021.01.015_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.oooo.2013.08.028","article-title":"Malignancy mimicking bisphosphonate-associated osteonecrosis of the jaw: a case series and literature review","volume":"117","author":"Gander","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jfma.2021.01.015_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jds.2013.03.004","article-title":"Retrospective analysis of 27 cases of bisphosphonate-related osteonecrosis of the jaw treated surgically or non-surgically","volume":"9","author":"Lu","year":"2014","journal-title":"J Dent Sci"},{"key":"10.1016\/j.jfma.2021.01.015_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1034\/j.1600-0609.2002.02796.x","article-title":"Bisphosphonate therapy in multiple myeloma, past, present, future","volume":"69","author":"Jantunen","year":"2002","journal-title":"Eur J Hematol"},{"key":"10.1016\/j.jfma.2021.01.015_bib37","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jamaoncol.2016.6316","article-title":"Continued treatment effect of zoledronic acid dosing every 12 vs 4 Weeks in women with breast cancer metastatic to bone: the OPTIMIZE-2 randomized clinical trial","volume":"3","author":"Hortobagyi","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jfma.2021.01.015_bib38","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1210\/jc.2015-1794","article-title":"Declining incidence of medication-related osteonecrosis of the jaw in patients with cancer","volume":"100","author":"Sim","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2021.01.015_bib39","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jfma.2021.01.015_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.12968\/denu.2018.45.5.383","article-title":"Oral and Dental management for people with multiple myeloma: clinical guidance for dental care providers","volume":"45","author":"Abed","year":"2018","journal-title":"Dent Update"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:45:13Z","timestamp":1760539513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664621000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0929664621000371"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.01.015","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}